Summary
The University of Basel and University Hospitals Basel are seeking applications for two PhD students specializing in protective B cell immunity against the Lassa virus (LASV). This research aims to address the lack of a clinical vaccine for LASV, which causes significant morbidity and mortality in West Africa.
PhD Students in Vaccination-Induced B Cell Immunity Against Lassa Virus, University of Basel, Switzerland
Designation
PhD Students in Experimental Virology
Research Area
- Protective B cell immunity against Lassa virus
- Genetic vaccine technology
- Immunological and virological methods
Location
University of Basel, Basel, Switzerland
Eligibility/Qualification
- Basic knowledge in immunology is required
- Prior experience in immunological or virological research and/or molecular biological approaches is a plus
- Strong desire to learn and contribute to fundamental discoveries
- Team spirit and social skills are essential
Job Description
Successful candidates will:
- Investigate the elicitation of protective memory B cell immunity through genetic vaccine technology
- Explore how memory B cell immunity confers protection against high-level viremia
- Utilize cutting-edge methods such as molecular vaccine design, B cell repertoire analyses, and somatic gene therapy-based perturbation experiments in mice
How to Apply
Interested candidates should submit their applications via the online recruiting tool. Required documents include:
- CV
- Motivation letter
- Names and contact details of at least two referees
Last Date to Apply
To be announced (please check the official website for updates).
For more information, please visit: University of Basel
